These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 19821939)

  • 1. Intrathoracic and ventricular impedances are associated with changes in ventricular volume in patients receiving defibrillators for CRT.
    Maines M; Landolina M; Lunati M; Lonardi G; Pappone A; Proclemer A; Zanotto G; Santini M; Varbaro A; Vimercati M; Valsecchi S;
    Pacing Clin Electrophysiol; 2010 Jan; 33(1):64-73. PubMed ID: 19821939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of right ventricular lead location on response to cardiac resynchronization therapy in patients with end-stage heart failure.
    Haghjoo M; Bonakdar HR; Jorat MV; Fazelifar AF; Alizadeh A; Ojaghi-Haghjghi Z; Esmaielzadeh M; Sadr-Ameli MA
    Europace; 2009 Mar; 11(3):356-63. PubMed ID: 19136489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anodal right ventricular capture during left ventricular stimulation in CRT-implantable cardioverter defibrillators.
    Thibault B; Roy D; Guerra PG; Macle L; Dubuc M; Gagné P; Greiss I; Novak P; Furlani A; Talajic M
    Pacing Clin Electrophysiol; 2005 Jul; 28(7):613-9. PubMed ID: 16008795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intracardiac impedance monitors stroke volume in resynchronization therapy patients.
    Bocchiardo M; Meyer zu Vilsendorf D; Militello C; Lippert M; Czygan G; Gaita F; Schauerte P; Stellbrink C
    Europace; 2010 May; 12(5):702-7. PubMed ID: 20185482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of cardiac resynchronization therapy on disease progression in patients with congestive heart failure.
    Bonanno C; Ometto R; Pasinato S; Finocchi G; La Vecchia L; Fontanelli A
    Ital Heart J; 2004 May; 5(5):364-70. PubMed ID: 15185900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of disease progression by cardiac resynchronization therapy in patients with asymptomatic or mildly symptomatic left ventricular dysfunction: insights from the European cohort of the REVERSE (Resynchronization Reverses Remodeling in Systolic Left Ventricular Dysfunction) trial.
    Daubert C; Gold MR; Abraham WT; Ghio S; Hassager C; Goode G; Szili-Török T; Linde C;
    J Am Coll Cardiol; 2009 Nov; 54(20):1837-46. PubMed ID: 19800193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple vector impedance measurements during biventricular pacing: feasibility and possible implications for hemodynamic monitoring.
    Valzania C; Eriksson MJ; Holmström N; Järverud K; Gadler F
    Pacing Clin Electrophysiol; 2009 Dec; 32(12):1492-500. PubMed ID: 19732361
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Similar long-term benefits conferred by apical versus mid-septal implantation of the right ventricular lead in recipients of cardiac resynchronization therapy systems.
    Bulava A; Lukl J
    Pacing Clin Electrophysiol; 2009 Mar; 32 Suppl 1():S32-7. PubMed ID: 19250108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term prognosis after cardiac resynchronization therapy is related to the extent of left ventricular reverse remodeling at midterm follow-up.
    Ypenburg C; van Bommel RJ; Borleffs CJ; Bleeker GB; Boersma E; Schalij MJ; Bax JJ
    J Am Coll Cardiol; 2009 Feb; 53(6):483-90. PubMed ID: 19195605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiac resynchronization therapy in patients with intrinsic and right ventricular pacing-induced left bundle branch block pattern.
    Shen X; Aronow WS; Holmberg MJ; Li H; Nair CK; Korlakunta H; Esterbrooks DJ
    Am J Ther; 2009; 16(6):e44-50. PubMed ID: 19940605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of acute changes in left ventricular volume, systolic and diastolic functions, and intraventricular synchronicity after biventricular and right ventricular pacing for heart failure.
    Yu CM; Lin H; Fung WH; Zhang Q; Kong SL; Sanderson JE
    Am Heart J; 2003 May; 145(5):E18. PubMed ID: 12766742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Continuous monitoring of intrathoracic impedance and right ventricular pressures in patients with heart failure.
    Vanderheyden M; Houben R; Verstreken S; Ståhlberg M; Reiters P; Kessels R; Braunschweig F
    Circ Heart Fail; 2010 May; 3(3):370-7. PubMed ID: 20197559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential change in left ventricular mass and regional wall thickness after cardiac resynchronization therapy for heart failure.
    Zhang Q; Fung JW; Auricchio A; Chan JY; Kum LC; Wu LW; Yu CM
    Eur Heart J; 2006 Jun; 27(12):1423-30. PubMed ID: 16682380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Upgrading to biventricular pacing guided by pressure-volume loop analysis during implantation.
    Delnoy PP; Ottervanger JP; Vos DH; Elvan A; Misier AR; Beukema WP; Steendijk P; van Hemel NM
    J Cardiovasc Electrophysiol; 2011 Jun; 22(6):677-83. PubMed ID: 21134027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of cardiac resynchronization on disease progression in patients with left ventricular systolic dysfunction, an indication for an implantable cardioverter-defibrillator, and mildly symptomatic chronic heart failure.
    Abraham WT; Young JB; León AR; Adler S; Bank AJ; Hall SA; Lieberman R; Liem LB; O'Connell JB; Schroeder JS; Wheelan KR;
    Circulation; 2004 Nov; 110(18):2864-8. PubMed ID: 15505095
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pressure-volume loop analysis during implantation of biventricular pacemaker/cardiac resynchronization therapy device to optimize right and left ventricular pacing sites.
    Delnoy PP; Ottervanger JP; Luttikhuis HO; Vos DH; Elvan A; Ramdat Misier AR; Beukema WP; Steendijk P; van Hemel NM
    Eur Heart J; 2009 Apr; 30(7):797-804. PubMed ID: 19202156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Usefulness of QRS duration to predict response to cardiac resynchronization therapy in patients with end-stage heart failure.
    Mollema SA; Bleeker GB; van der Wall EE; Schalij MJ; Bax JJ
    Am J Cardiol; 2007 Dec; 100(11):1665-70. PubMed ID: 18036366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiac resynchronisation therapy in patients with end-stage heart failure--long-term follow-up.
    Faran A; Lewicka-Nowak E; Dabrowska-Kugacka A; Kempa M; Tybura S; Szwoch M; Królak T; Raczak G
    Kardiol Pol; 2008 Jan; 66(1):19-26; discussion 27. PubMed ID: 18266184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiac resynchronization therapy in patients with end-stage inotrope-dependent class IV heart failure.
    Herweg B; Ilercil A; Cutro R; Dewhurst R; Krishnan S; Weston M; Barold SS
    Am J Cardiol; 2007 Jul; 100(1):90-3. PubMed ID: 17599447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dual-site left ventricular cardiac resynchronization therapy.
    Padeletti L; Colella A; Michelucci A; Pieragnoli P; Ricciardi G; Porciani MC; Tronconi F; Hettrick DA; Valsecchi S
    Am J Cardiol; 2008 Dec; 102(12):1687-92. PubMed ID: 19064025
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.